Eligibility Acute Myeloid Leukemia NCT00151255

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed aml defined according to the world health organization (who) classification (excluding acute promyelocytic leukemia [apl])
Descrição

newly diagnosed aml defined according to the world health organization (who) classification (excluding acute promyelocytic leukemia [apl])

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023467
aged > 60 years
Descrição

aged > 60 years

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
all patients have to be informed about the character of the study. written informed consent of each patient at study entry.
Descrição

all patients have to be informed about the character of the study. written informed consent of each patient at study entry.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
molecular and cytogenetical analyses on initial bone marrow and peripheral blood specimen have to be performed at the central reference laboratories.
Descrição

molecular and cytogenetical analyses on initial bone marrow and peripheral blood specimen have to be performed at the central reference laboratories.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2121080
UMLS CUI [2]
C0010802
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
bleeding independent of the aml
Descrição

bleeding independent of the aml

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019080
UMLS CUI [2]
C0023467
acute promyelocytic leukemia
Descrição

acute promyelocytic leukemia

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023487
uncontrolled infection
Descrição

uncontrolled infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
participation in a concurrent clinical study
Descrição

participation in a concurrent clinical study

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
insufficiency of the kidneys (creatinine > 1.5 x upper normal serum level), of the liver (bilirubin, ast or ap > 2 x upper normal serum level), severe obstruction or restrictive ventilation disorder, heart failure new york heart association [nyha] iii/iv
Descrição

insufficiency of the kidneys (creatinine > 1.5 x upper normal serum level), of the liver (bilirubin, ast or ap > 2 x upper normal serum level), severe obstruction or restrictive ventilation disorder, heart failure new york heart association [nyha] iii/iv

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201850
UMLS CUI [5]
C0035204
UMLS CUI [6]
C1275491
severe neurological or psychiatric disorder interfering with ability of giving informed consent
Descrição

severe neurological or psychiatric disorder interfering with ability of giving informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
no consent for the registration, storage and processing of data concerning the characteristics of the aml and the individual course
Descrição

no consent for the registration, storage and processing of data concerning the characteristics of the aml and the individual course

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
performance status who > 2
Descrição

performance status who > 2

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1298650

Similar models

Eligibility Acute Myeloid Leukemia NCT00151255

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
newly diagnosed aml defined according to the world health organization (who) classification (excluding acute promyelocytic leukemia [apl])
boolean
C0023467 (UMLS CUI [1])
Age
Item
aged > 60 years
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
all patients have to be informed about the character of the study. written informed consent of each patient at study entry.
boolean
C0021430 (UMLS CUI [1])
molecular and cytogenetical analyses
Item
molecular and cytogenetical analyses on initial bone marrow and peripheral blood specimen have to be performed at the central reference laboratories.
boolean
C2121080 (UMLS CUI [1])
C0010802 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
bleeding independent of the aml
Item
bleeding independent of the aml
boolean
C0019080 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
acute promyelocytic leukemia
Item
acute promyelocytic leukemia
boolean
C0023487 (UMLS CUI [1])
uncontrolled infection
Item
uncontrolled infection
boolean
C0009488 (UMLS CUI [1])
participation in a concurrent clinical study
Item
participation in a concurrent clinical study
boolean
C2348568 (UMLS CUI [1])
organ function
Item
insufficiency of the kidneys (creatinine > 1.5 x upper normal serum level), of the liver (bilirubin, ast or ap > 2 x upper normal serum level), severe obstruction or restrictive ventilation disorder, heart failure new york heart association [nyha] iii/iv
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C1275491 (UMLS CUI [6])
severe neurological or psychiatric disorder interfering with ability of giving informed consent
Item
severe neurological or psychiatric disorder interfering with ability of giving informed consent
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
no consent
Item
no consent for the registration, storage and processing of data concerning the characteristics of the aml and the individual course
boolean
C0021430 (UMLS CUI [1])
performance status who
Item
performance status who > 2
boolean
C1298650 (UMLS CUI [1])